Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug ...
The FDA accepted the investigational new drug application for UGN-103 in April 2024. These new positive data position the ...
GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to ...
Three individuals, Estelle le Grange, Leeroy Scholtz and Ankie-Marie Cilliers, face charges of conspiracy to commit murder, murder and robbery with aggravating circumstances.
Cohesive to aid in enabling a next generation, full-lifecycle asset management solution for the UK Armed Forces ...
A Lagos court adjourns the arraignment of an ex-director in a N20bn fraud case. The defendant is accused of laundering funds from a family inheritance.
Harrow has completed its deal to acquire Melt Pharmaceuticals, according to a company press release. Harrow announced its plan to acquire Melt in September and said it planned to submit a new drug ...
Information relating to Australian military programs was compromised in cyber attacks on defence industry contractors, ...
The Punch on MSN
Kanu’s new appeal renews focus on his 10-year trial
Explore the complex, decade-long Nnamdi Kanu trial. Learn about the shifting charges, appellate court interventions, and ...
Defence ministers raise concerns on China's mega-embassy in London amid 'complex' national security threats - Beijing has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback